|
1
|
Lee D, Wada K, Taniguchi Y, Al-Shareef H,
Masuda T, Usami Y, Aikawa T, Okura M, Kamisaki Y and Kogo M:
Expression of fatty acid binding protein 4 is involved in the cell
growth of oral squamous cell carcinoma. Oncol Rep. 31:1116–1120.
2014.PubMed/NCBI
|
|
2
|
Doshi NP, Shah SA, Patel KB and Jhabuawala
MF: Histological grading of oral cancer: A comparison of different
systems and their relation to lymph node metastasis. Nat J Commun
Med. 2:136–142. 2011.
|
|
3
|
Watanabe S, Kato M, Kotani I, Ryoke K and
Hayashi K: Lymphatic vessel density and vascular endothelial growth
factor expression in squamous cell carcinomas of lip and oral
cavity: A clinicopathological analysis with immunohistochemistry
using antibodies to D2-40, VEGF-C and VEGF-D. Yonago Acta Med.
56:29–37. 2013.PubMed/NCBI
|
|
4
|
Miyata Y, Kanda S, Ohba K, Nomata K,
Hayashida Y, Eguchi J, Hayashi T and Kanetake H: Lymphangiogenesis
and angiogenesis in bladder cancer: Prognostic implications and
regulation by vascular endothelial growth factors-A, -C, and -D.
Clin Cancer Res. 12:800–806. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hicklin DJ and Ellis LM: Role of the
vascular endothelial growth factor pathway in tumor growth and
angiogenesis. J Clin Oncol. 23:1011–1027. 2005. View Article : Google Scholar
|
|
6
|
Sugiura T, Inoue Y, Matsuki R, Ishii K,
Takahashi M, Abe M and Shirasuna K: VEGF-C and VEGF-D expression is
correlated with lymphatic vessel density and lymph node metastasis
in oral squamous cell carcinoma: Implications for use as a
prognostic marker. Int J Oncol. 34:673–680. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Staton CA, Koay I, Wu JM, Hoh L, Reed MW
and Brown NJ: Neuropilin-1 and neuropilin-2 expression in the
adenoma-carcinoma sequence of colorectal cancer. Histopathology.
62:908–915. 2013. View Article : Google Scholar
|
|
8
|
Kodama J, Hasengaowa, Kusumoto T, Seki N,
Matsuo T, Ojima Y, Nakamura K, Hongo A and Hiramatsu Y: Association
of CXCR4 and CCR7 chemokine receptor expression and lymph node
metastasis in human cervical cancer. Ann Oncol. 18:70–76. 2007.
View Article : Google Scholar
|
|
9
|
Ishida K, Iwahashi M, Nakamori M, Nakamura
M, Yokoyama S, Iida T, Naka T, Nakamura Y and Yamaue H: High CCR7
mRNA expression of cancer cells is associated with lymph node
involvement in patients with esophageal squamous cell carcinoma.
Int J Oncol. 34:915–922. 2009.PubMed/NCBI
|
|
10
|
Alattar M, Omo A, Elsharawy M and Li J:
Neuropilin-1 expression in squamous cell carcinoma of the
oesophagus. Eur J Cardiothorac Surg. 45:514–520. 2014. View Article : Google Scholar
|
|
11
|
Nasarre P, Gemmill RM and Drabkin HA: The
emerging role of class-3 semaphorins and their neuropilin receptors
in oncology. Onco Targets Ther. 7:1663–1687. 2014.PubMed/NCBI
|
|
12
|
Kumanogoh A and Kikutani H: Immunological
functions of the neuropilins and plexins as receptors for
semaphorins. Nat Rev Immunol. 13:802–814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Klagsbrun M and Shimizu A: Semaphorin 3E,
an exception to the rule. J Clin Invest. 120:2658–2660. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Casazza A, Finisguerra V, Capparuccia L,
Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti
A, Sarotto I, et al: Sema3E-Plexin D1 signaling drives human cancer
cell invasiveness and metastatic spreading in mice. J Clin Invest.
120:2684–2698. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luchino J, Hocine M, Amoureux MC, Gibert
B, Bernet A, Royet A, Treilleux I, Lécine P, Borg JP, Mehlen P, et
al: Semaphorin 3E suppresses tumor cell death triggered by the
plexin D1 dependence receptor in metastatic breast cancers. Cancer
Cell. 24:673–685. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Franceschi S, Bidoli E, Herrero R and
Muñoz N: Comparison of cancers of the oral cavity and pharynx
worldwide: Etiological clues. Oral Oncol. 36:106–115. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Anagnostou VK, Tiniakos DG, Fotinou M,
Achimastos A and Syrigos KN: Multiplexed analysis of angiogenesis
and lymphangiogenesis factors predicts outcome for non-small cell
lung cancer patients. Virchows Arch. 458:331–340. 2011. View Article : Google Scholar
|
|
18
|
Izumo T, Kirita T, Ariji E, Ozeki S, Okada
N, Okabe S, Okazaki Y, Omura K, Kusama M, Sato T, et al: Working
Group 1 on the ʻGuidelines for Clinical and Pathological Studies of
Oral Cancerʼ, Scientific Committee, Japan Society for Oral Tumors:
General rules for clinical and pathological studies on oral cancer:
A synopsis. Jpn J Clin Oncol. 42:1099–1109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamamoto E, Kohama G, Sunakawa H, Iwai M
and Hiratsuka H: Mode of invasion, bleomycin sensitivity, and
clinical course in squamous cell carcinoma of the oral cavity.
Cancer. 51:2175–2180. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamamoto E, Miyakawa A and Kohama G: Mode
of invasion and lymph node metastasis in squamous cell carcinoma of
the oral cavity. Head Neck Surg. 6:938–947. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Barnes DM, Harris WH, Smith P, Millis RR
and Rubens RD: Immunohistochemical determination of oestrogen
receptor: Comparison of different methods of assessment of staining
and correlation with clinical outcome of breast cancer patients. Br
J Cancer. 74:1445–1451. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding Y, Shimada Y, Maeda M, Kawabe A,
Kaganoi J, Komoto I, Hashimoto Y, Miyake M, Hashida H and Imamura
M: Association of CC chemokine receptor 7 with lymph node
metastasis of esophageal squamous cell carcinoma. Clin Cancer Res.
9:3406–3412. 2003.PubMed/NCBI
|
|
23
|
Krajewska M, Krajewski S, Epstein JI,
Shabaik A, Sauvageot J, Song K, Kitada S and Reed JC:
Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1
expression in prostate cancers. Am J Pathol. 148:1567–1576.
1996.PubMed/NCBI
|
|
24
|
Remmele W and Stegner HE:
Immunhistochemischer nachweis von östrogenerezeptoren (ER-ICA) im
mammakarizi-nomgewebe: Vorschlag zur einheitlichen bewertung des
untersu- chungsbefundes. Frauenarzt. 28:41–43. 1987.
|
|
25
|
Weidner N, Semple J, Welch W and Folkman
J: Tumor angiogenesis and metastasis - correlation in invasive
breast carcinoma. N Engl J Med. 324:1–8. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang
S, Wang W, Zhang J and Zhang Y: RNAi-mediated silencing of VEGF-C
inhibits non-small cell lung cancer progression by simultaneously
down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent
axes-induced ERK, p38 and AKT signalling pathways. Eur J Cancer.
47:2353–2363. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Niki T, Iba S, Tokunou M, Yamada T,
Matsuno Y and Hirohashi S: Expression of vascular endothelial
growth factors A, B, C, and D and their relationships to lymph node
status in lung adenocarcinoma. Clin Cancer Res. 6:2431–2439.
2000.PubMed/NCBI
|
|
28
|
George ML, Tutton MG, Janssen F, Arnaout
A, Abulafi AM, Eccles SA and Swift RI: VEGF-A, VEGF-C, and VEGF-D
in colorectal cancer progression. Neoplasia. 3:420–427. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shintani S, Li C, Ishikawa T, Mihara M,
Nakashiro K and Hamakawa H: Expression of vascular endothelial
growth factor A, B, C, and D in oral squamous cell carcinoma. Oral
Oncol. 40:13–20. 2004. View Article : Google Scholar
|
|
30
|
Kitadai Y, Amioka T, Haruma K, Tanaka S,
Yoshihara M, Sumii K, Matsutani N, Yasui W and Chayama K:
Clinicopathological significance of vascular endothelial growth
factor (VEGF)-C in human esophageal squamous cell carcinomas. Int J
Cancer. 93:662–666. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lalla RV, Boisoneau DS, Spiro JD and
Kreutzer DL: Expression of vascular endothelial growth factor
receptors on tumor cells in head and neck squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg. 129:882–888. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sanmartín E, Sirera R, Usó M, Blasco A,
Gallach S, Figueroa S, Martínez N, Hernando C, Honguero A,
Martorell M, et al: A gene signature combining the tissue
expression of three angiogenic factors is a prognostic marker in
early-stage non-small cell lung cancer. Ann Surg Oncol. 21:612–620.
2014. View Article : Google Scholar
|
|
33
|
Iljin K, Karkkainen MJ, Lawrence EC, Kimak
MA, Uutela M, Taipale J, Pajusola K, Alhonen L, Halmekytö M,
Finegold DN, et al: VEGFR3 gene structure, regulatory region, and
sequence polymorphisms. FASEB J. 15:1028–1036. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Neuchrist C, Erovic BM, Handisurya A,
Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A and
Burian M: Vascular endothelial growth factor C and vascular
endothelial growth factor receptor 3 expression in squamous cell
carcinomas of the head and neck. Head Neck. 25:464–474. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Su JL, Yang PC, Shih JY, Yang CY, Wei LH,
Hsieh CY, Chou CH, Jeng YM, Wang MY, Chang KJ, et al: The
VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells.
Cancer Cell. 9:209–223. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chaudary N, Milosevic M and Hill RP:
Suppression of vascular endothelial growth factor receptor 3
(VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits
hypoxia-induced lymph node metastases in cervix cancer. Gynecol
Oncol. 123:393–400. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhan P, Wang J, Lv XJ, Wang Q, Qiu LX, Lin
XQ, Yu LK and Song Y: Prognostic value of vascular endothelial
growth factor expression in patients with lung cancer: A systematic
review with meta-analysis. J Thorac Oncol. 4:1094–1103. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Carrillo de Santa Pau E, Arias FC, Caso
Peláez E, Muñoz Molina GM, Sánchez Hernández I, Muguruza Trueba I,
Moreno Balsalobre R, Sacristán López S, Gómez Pinillos A and del
Val Toledo Lobo M: Prognostic significance of the expression of
vascular endothelial growth factors A, B, C, and D and their
receptors R1, R2, and R3 in patients with nonsmall cell lung
cancer. Cancer. 115:1701–1712. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Maekawa S, Iwasaki A, Shirakusa T, Enatsu
S, Kawakami T and Kuroki M and Kuroki M: Correlation between lymph
node metastasis and the expression of VEGF-C, VEGF-D and VEGFR-3 in
T1 lung adenocarcinoma. Anticancer Res. 27:3735–3741.
2007.PubMed/NCBI
|
|
40
|
Saintigny P, Kambouchner M, Ly M, Gomes N,
Sainte-Catherine O, Vassy R, Czernichow S, Letoumelin P, Breau JL,
Bernaudin JF, et al: Vascular endothelial growth factor-C and its
receptor VEGFR-3 in non-small-cell lung cancer: Concurrent
expression in cancer cells from primary tumour and metastatic lymph
node. Lung Cancer. 58:205–213. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pitkin L, Luangdilok S, Corbishley C,
Wilson POG, Dalton P, Bray D, Mady S, Williamson P, Odutoye T, Rhys
Evans P, et al: Expression of CC chemokine receptor 7 in tonsillar
cancer predicts cervical nodal metastasis, systemic relapse and
survival. Br J Cancer. 97:670–677. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bender RJ and Mac Gabhann F: Dysregulation
of the vascular endothelial growth factor and semaphorin
ligand-receptor families in prostate cancer metastasis. BMC Syst
Biol. 9:552015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Song X, Zhang W, Zhang Y, Zhang H, Fu Z,
Ye J, Liu L, Song X and Wu Y: Expression of semaphorin 3A and
neuropilin 1 with clinicopathological features and survival in
human tongue cancer. Med Oral Patol Oral Cir Bucal. 17:e962–e968.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cagnoni G and Tamagnone L: Semaphorin
receptors meet receptor tyrosine kinases on the way of tumor
progression. Oncogene. 33:4795–4802. 2014. View Article : Google Scholar
|
|
45
|
Tamagnone L and Rehman M: To die or not to
die: Sema3E rules the game. Cancer Cell. 24:564–566. 2013.
View Article : Google Scholar : PubMed/NCBI
|
